Proudly joining wet lab incubator @SpinUpUTM on #UTM campus, thrilled to be @Merck Blue Ticket winners, even more focused on advancing kidney failure treatments.
Beyond thrilled to be moving in to @SpinUpUTM AND on winning the Blue Ticket. The financial support and mentoring from @Merck and the facilities and programming at SpinUp will truly help us to accelerate and get our kidney treatment to patients faster.
Congratulations to the Atorvia team! The emerging woman-led biotech company is SpinUp's first-ever Blue Ticket winner. Learn about their mission to treat acute kidney injury — and how @Merck's mentorship and support will help Atorvia reach its goal.
We are thrilled to be presenting to global investors at the 2024 #OBIOInvestmentSummit! The Summit features Canada’s most investible health science companies commercializing products & services in therapeutics, medical devices, diagnostics & more.
https://t.co/FyYo8iZZno
Cost should never be a barrier to patients accessing the care they need. Unfortunately, Congress has created a proposal that will not reduce costs for individual patients, and is likely to disincentivize investment, hog-tie innovation, and cost jobs. https://t.co/0WzUBddL0S
Join @EMDSerono @TakedaPharma & @AstraZeneca for #lifesciences’ premier innovation summit! Our #PartneringWeek is an interactive experience that connects emerging companies with the partners & resources they need to take their businesses to the next level. https://t.co/z1cMq1qOO5
We recently sat down with the founders from #MassBioDrive’s spring 2022 cohort to learn a little more about their experience in the program and plans beyond the accelerator. Check out what they had to say (and apply by July 1 to join the fall 2022 cohort) https://t.co/wObFzlalVJ
Some insight from the CEO’s of the #MBDS22 cohort about the @MassBio program, how it benefited our businesses and what progress we were all able to make as a result.
Applications for the fall are still open!
https://t.co/7ThidBHbZa
@atorvia_co CEO on her #MassBioDrive experience: “The program was transformational. It got us ready to launch an efficient and effective capital raise process for seed funding.”
To join the next cohort, apply by 7/1: https://t.co/mNKwjAtkC8
Starting a biotech is complex & challenging - but it’s also a gift. As an industry, we are developing tech that has the potential to transform the lives of patients. Accelerators like MassbioDrive helps biotechs to be successful beyond the science. https://t.co/1jIE93UvGh